
aTyr Pharma, Inc.
ATYRHealthcare|Biotechnology|US
$6.35
+0.32 (+5.31%)
Tangible Book / Share
$13.76
Cash / Share
$20.46
Next Earnings Report
Mar 4, 2027
EPS est. -$4.60 · Revenue est. $9.7M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
Oct 29, 2026 · GlobeNewsWire
aTyr Pharma Announces One-for-40 Reverse Stock Split
Oct 27, 2026 · GlobeNewsWire
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
Oct 19, 2026 · GlobeNewsWire
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
Oct 13, 2026 · GlobeNewsWire
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Sep 24, 2026 · GlobeNewsWire
SEC Filings (58)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Nov 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 4, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 16, 2026 | 8-K | Material event | DocumentIndex |
| Oct 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 24, 2026 | 8-K | Material event | DocumentIndex |
| Sep 11, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 31, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 7, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Aug 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 8, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 1, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | ARS | Annual report to holders | DocumentIndex |
| Mar 26, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 26, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 12, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 5, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Dec 5, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Oct 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 15, 2025 | 8-K | Material event | DocumentIndex |
| Aug 18, 2025 | EFFECT | DocumentIndex | |
| Aug 8, 2025 | 8-K/A | Material event | DocumentIndex |
| Aug 7, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 7, 2025 | S-3 | Shelf registration | DocumentIndex |